Altimmune Announces Important Additions to its Patent Portfolio for HepTcell and ALT-702 Programs Yahoo Finance
Altimmune, Inc. (ALT), a clinical-stage biotechnology company, today announced that it has received additional patent protection for its HepTcell and ALT-702 …